|
OMIM |
Link |
Information gain |
01 |
|
FTD
|
[NCBI]
|
0.0393218
|
|
|
AD
|
[NCBI]
|
0.00586782
|
|
|
kohlschutter-tonz syndrome
|
[NCBI]
|
0.00400847
|
|
|
ALSFTD1
|
[NCBI]
|
0.00325536
|
|
|
ALSFTD2
|
[NCBI]
|
0.00287941
|
|
|
APOE
|
[NCBI]
|
0.00245289
|
|
|
MAPT
|
[NCBI]
|
0.00201794
|
|
|
SLE
|
[NCBI]
|
0.00172128
|
|
|
GRN
|
[NCBI]
|
0.00117441
|
|
|
FTLDU
|
[NCBI]
|
0.00113134
|
|
|
angiomatosis, diffuse corticomeningeal, of divry and van bogaert
|
[NCBI]
|
0.000952205
|
|
|
cataract, congenital, with mental impairment and dentate gyrus atrophy
|
[NCBI]
|
0.000734606
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
0.000669605
|
|
|
ACHE
|
[NCBI]
|
0.000667592
|
|
|
FTD3
|
[NCBI]
|
0.000600534
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.000599634
|
|
|
PSNP2
|
[NCBI]
|
0.000560268
|
|
|
CJD
|
[NCBI]
|
0.00055529
|
|
|
SPG15
|
[NCBI]
|
0.000528971
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.000528971
|
|
|
pick disease of brain
|
[NCBI]
|
0.000526714
|
|
|
CHAT
|
[NCBI]
|
0.000521617
|
|
|
CLN4B
|
[NCBI]
|
0.000503004
|
|
|
PLOSL
|
[NCBI]
|
0.000502806
|
|
|
PARK3
|
[NCBI]
|
0.000444338
|
|
|
gliosis, familial progressive subcortical
|
[NCBI]
|
0.000435222
|
|
|
CARASIL
|
[NCBI]
|
0.00042895
|
|
|
PD
|
[NCBI]
|
0.000351836
|
|
|
DRPLA
|
[NCBI]
|
0.000329755
|
|
|
amyloidosis vi
|
[NCBI]
|
0.00029857
|
|
|
PCD
|
[NCBI]
|
0.000278404
|
|
|
CADASIL
|
[NCBI]
|
0.000268942
|
|
|
CHMP2B
|
[NCBI]
|
0.000265546
|
|
|
KRS
|
[NCBI]
|
0.000249711
|
|
|
ITM2B
|
[NCBI]
|
0.000233865
|
|
|
VCP
|
[NCBI]
|
0.000226036
|
|
|
FDD
|
[NCBI]
|
0.00021754
|
|
|
DRPLA
|
[NCBI]
|
0.000182342
|
|
|
FBD
|
[NCBI]
|
0.000181263
|
|
|
DLB
|
[NCBI]
|
0.000178763
|
|
|
GSD
|
[NCBI]
|
0.000170767
|
|
|
opticoacoustic nerve atrophy with dementia
|
[NCBI]
|
0.000145011
|
|
|
mast syndrome
|
[NCBI]
|
0.000145011
|
|
|
acidic cluster protein, 33-kd
|
[NCBI]
|
0.000116883
|
|
|
amyloidosis, cerebroarterial, hereditary, iowa type
|
[NCBI]
|
0.000114242
|
|
|
PRNP
|
[NCBI]
|
0.00011254
|
|
|
TNF
|
[NCBI]
|
0.00010899
|
|
|
APP
|
[NCBI]
|
0.000100834
|
|
|
PSEN1
|
[NCBI]
|
8.03738e-05
|
|
|
SCA17
|
[NCBI]
|
7.90204e-05
|
|
|
PWS
|
[NCBI]
|
7.77681e-05
|
|
|
CD
|
[NCBI]
|
7.61321e-05
|
|
|
APBD
|
[NCBI]
|
7.32003e-05
|
|
|
IBMPFD
|
[NCBI]
|
7.32003e-05
|
|
|
spinocerebellar ataxia, x-linked 4
|
[NCBI]
|
7.24976e-05
|
|
|
spastic paraplegia, optic atrophy, and dementia
|
[NCBI]
|
7.24976e-05
|
|
|
charcot-marie-tooth disease with ptosis and parkinsonism
|
[NCBI]
|
7.24976e-05
|
|
|
dementia/parkinsonism with non-alzheimer amyloid plaques
|
[NCBI]
|
7.24976e-05
|
|
|
SDSEM
|
[NCBI]
|
7.24976e-05
|
|
|
presenile dementia, kraepelin type
|
[NCBI]
|
7.24976e-05
|
|
|
motor neuron disease with dementia and ophthalmoplegia
|
[NCBI]
|
7.24976e-05
|
|
|
ataxia with myoclonic epilepsy and presenile dementia
|
[NCBI]
|
7.24976e-05
|
|
|
senile plaque formation
|
[NCBI]
|
7.24976e-05
|
|
|
PARK4
|
[NCBI]
|
6.90309e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
6.83344e-05
|
|
|
PSEN2
|
[NCBI]
|
6.10652e-05
|
|
|
NCSTN
|
[NCBI]
|
6.01409e-05
|
|
|
PAFAH1B3
|
[NCBI]
|
5.84295e-05
|
|
|
FMNL
|
[NCBI]
|
5.84295e-05
|
|
|
oncogene dj1
|
[NCBI]
|
5.73465e-05
|
|
|
HCHWAD
|
[NCBI]
|
5.41672e-05
|
|
|
SNCA
|
[NCBI]
|
5.33059e-05
|
|
|
alzheimer disease without neurofibrillary tangles
|
[NCBI]
|
5.0211e-05
|
|
|
FXTAS
|
[NCBI]
|
4.79823e-05
|
|
|
GFAP
|
[NCBI]
|
4.69972e-05
|
|
|
ATP13A2
|
[NCBI]
|
4.46766e-05
|
|
|
TCL6
|
[NCBI]
|
4.46766e-05
|
|
|
PI12
|
[NCBI]
|
4.46766e-05
|
|
|
CLK2
|
[NCBI]
|
4.46766e-05
|
|
|
BCYRN1
|
[NCBI]
|
4.46766e-05
|
|
|
FENIB
|
[NCBI]
|
4.1915e-05
|
|
|
parkinson-dementia syndrome
|
[NCBI]
|
4.1915e-05
|
|
|
BCHE
|
[NCBI]
|
4.07706e-05
|
|
|
PTH
|
[NCBI]
|
4.02155e-05
|
|
|
MAP3K14
|
[NCBI]
|
3.9503e-05
|
|
|
APBB1
|
[NCBI]
|
3.9503e-05
|
|
|
spongiform encephalopathy with neuropsychiatric features
|
[NCBI]
|
3.65928e-05
|
|
|
spastic ataxia
|
[NCBI]
|
3.65928e-05
|
|
|
haw river syndrome
|
[NCBI]
|
3.65928e-05
|
|
|
TARDBP
|
[NCBI]
|
3.6153e-05
|
|
|
NOVA2
|
[NCBI]
|
3.6153e-05
|
|
|
PSNP1
|
[NCBI]
|
3.51745e-05
|
|
|
EPO
|
[NCBI]
|
3.51222e-05
|
|
|
MTTW
|
[NCBI]
|
3.36691e-05
|
|
|
PDB
|
[NCBI]
|
3.20565e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
3.20565e-05
|
|
|
EGFR
|
[NCBI]
|
3.03682e-05
|
|
|
ANXA2
|
[NCBI]
|
3.00586e-05
|
|
|
TREM2
|
[NCBI]
|
3.00586e-05
|
|
|
dystonia, familial, with visual failure and striatal lucencies
|
[NCBI]
|
2.9605e-05
|
|
|
PMF
|
[NCBI]
|
2.9605e-05
|
|
|
HDL1
|
[NCBI]
|
2.9605e-05
|
|
|
HD
|
[NCBI]
|
2.95623e-05
|
|
|
UBB
|
[NCBI]
|
2.86615e-05
|
|
|
ESR1
|
[NCBI]
|
2.84928e-05
|
|
|
RASSF1
|
[NCBI]
|
2.74435e-05
|
|
|
LRRK2
|
[NCBI]
|
2.72408e-05
|
|
|
SANDO
|
[NCBI]
|
2.70768e-05
|
|
|
SPG4
|
[NCBI]
|
2.68756e-05
|
|
|
C10ORF2
|
[NCBI]
|
2.63646e-05
|
|
|
DCTN1
|
[NCBI]
|
2.63646e-05
|
|
|
SNCG
|
[NCBI]
|
2.63646e-05
|
|
|
CYP27A1
|
[NCBI]
|
2.63646e-05
|
|
|
H6PD
|
[NCBI]
|
2.53967e-05
|
|
|
CHAC
|
[NCBI]
|
2.5394e-05
|
|
|
IBM3
|
[NCBI]
|
2.49392e-05
|
|
|
NOTCH3
|
[NCBI]
|
2.45196e-05
|
|
|
MYD88
|
[NCBI]
|
2.45196e-05
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
2.30937e-05
|
|
|
ATXN3
|
[NCBI]
|
2.22977e-05
|
|
|
C4A
|
[NCBI]
|
2.05113e-05
|
|
|
VLDLR
|
[NCBI]
|
2.05113e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
2.00373e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
2.00373e-05
|
|
|
AACT
|
[NCBI]
|
1.85759e-05
|
|
|
PRL
|
[NCBI]
|
1.82733e-05
|
|
|
TBP
|
[NCBI]
|
1.81517e-05
|
|
|
PARK1
|
[NCBI]
|
1.75814e-05
|
|
|
NM
|
[NCBI]
|
1.65194e-05
|
|
|
NPC1
|
[NCBI]
|
1.56537e-05
|
|
|
fucosidosis
|
[NCBI]
|
1.50573e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
1.46513e-05
|
|
|
FFI
|
[NCBI]
|
1.45653e-05
|
|
|
APCS
|
[NCBI]
|
1.28095e-05
|
|
|
A2M
|
[NCBI]
|
1.23861e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
1.23861e-05
|
|
|
CLU
|
[NCBI]
|
1.14196e-05
|
|
|
IBM2
|
[NCBI]
|
1.10487e-05
|
|
|
CAT
|
[NCBI]
|
1.05415e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
1.04626e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
9.91168e-06
|
|
|
EAOH
|
[NCBI]
|
9.91168e-06
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
9.91168e-06
|
|
|
IDE
|
[NCBI]
|
9.51477e-06
|
|
|
OXT
|
[NCBI]
|
9.51477e-06
|
|
|
AAA
|
[NCBI]
|
9.39283e-06
|
|
|
CP
|
[NCBI]
|
9.39122e-06
|
|
|
MJD
|
[NCBI]
|
9.33396e-06
|
|
|
VIP
|
[NCBI]
|
8.16693e-06
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
7.58915e-06
|
|
|
ALS1
|
[NCBI]
|
7.47231e-06
|
|
|
MTTL1
|
[NCBI]
|
7.09492e-06
|
|
|
MCP
|
[NCBI]
|
7.09492e-06
|
|
|
homocysteinemia
|
[NCBI]
|
6.82336e-06
|
|
|
GBA
|
[NCBI]
|
6.63521e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
6.46909e-06
|
|
|
PNKD1
|
[NCBI]
|
5.8118e-06
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
5.8118e-06
|
|
|
PLTP
|
[NCBI]
|
5.3758e-06
|
|
|
GAL
|
[NCBI]
|
4.65951e-06
|
|
|
ADA
|
[NCBI]
|
4.54544e-06
|
|
|
AVP
|
[NCBI]
|
4.32994e-06
|
|
|
SST
|
[NCBI]
|
4.25454e-06
|
|
|
TH
|
[NCBI]
|
4.22678e-06
|
|
|
CRH
|
[NCBI]
|
4.09372e-06
|
|
|
MAP2
|
[NCBI]
|
3.93478e-06
|
|
|
ALB
|
[NCBI]
|
3.4007e-06
|
|
|
MDD
|
[NCBI]
|
2.52558e-06
|
|
|
RTT
|
[NCBI]
|
2.416e-06
|
|
|
CCK
|
[NCBI]
|
2.08029e-06
|
|
|
CSA
|
[NCBI]
|
1.76158e-06
|
|
|
neuraminidase deficiency
|
[NCBI]
|
1.76158e-06
|
|
|
PYY
|
[NCBI]
|
1.43462e-06
|
|
|
ALD
|
[NCBI]
|
1.35722e-06
|
|
|
SCA7
|
[NCBI]
|
1.31621e-06
|
|
|
SOD1
|
[NCBI]
|
6.36216e-07
|
|
|
NPY
|
[NCBI]
|
4.30363e-07
|
|
|
TTR
|
[NCBI]
|
3.93369e-07
|
|
|
PI
|
[NCBI]
|
3.901e-07
|
|
|
MBP
|
[NCBI]
|
3.50062e-07
|
|
|
CHS
|
[NCBI]
|
3.29706e-07
|
|
|
SMS
|
[NCBI]
|
3.21632e-07
|
|
|
NPC1
|
[NCBI]
|
1.85723e-07
|
|
|
NGFB
|
[NCBI]
|
1.5888e-07
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
1.5586e-07
|
|
|
SCA1
|
[NCBI]
|
1.52763e-07
|
|
|
SCA2
|
[NCBI]
|
8.30587e-08
|
|
|
HP
|
[NCBI]
|
7.7492e-08
|
|
|
BDNF
|
[NCBI]
|
6.40088e-08
|
|
|
GAPDH
|
[NCBI]
|
3.1537e-08
|
|
|
TF
|
[NCBI]
|
1.73319e-08
|
|
|
COMT
|
[NCBI]
|
9.07752e-09
|
|